- Fortuna L R, Brown I C, Woods G G L, Porche M. V. The impact of COVID-19 on anxiety disorders in youth: Coping with stress, worry, and recovering from a pandemic. CAPCNA 2023; 32(3): 531-542.
- Hallam C, Simmonds-Buckley M, Kellett S, Greenhill B, Jones A. The acceptability, effectiveness, and durability of cognitive analytic therapy: Systematic review and meta-analysis. PP 2021; 94(1): 8-35.
- Jashnani Z, Ghamari M, Kashani Vahid L. Presenting a model of the tendency to self-harming behaviors of teenagers on cyberspace addiction with the mediation of cognitive emotion regulation. PDMD 2024; 2(4): 127-135.
- Liu Q, Zhou B, Zhang X, Qing P, Zhou X, Zhou F, & et al. Abnormal multi-layered dynamic cortico-subcortical functional connectivity in major depressive disorder and generalized anxiety disorder. JPR 2023; 167(12): 23-31.
- Moore E W G, Petrie T A, Slavin L E. College student-athletes' COVID-19 worry and psychological distress differed by gender, race, and exposure to COVID-19–related events. JAH 2022; 70(4): 559-566.
- Power N, Kellett S & Gaskell C. Effectiveness of cognitive analytic therapy for mixed anxiety and depression in the context of borderline traits: A quasi-experimental single case design evaluation. JPI 2023; 33(1): 34-46.
- Reyhani S, Ahovan M. The effectiveness of emotional schema therapy on regulating emotions and reducing high-risk behaviors in female adolescents . RBS 2024; 22(1): 137-149.[Persian]
- Stefan S, Stroian P, Fodor L, Matu S, Nechita D, Boldea I, et al. An online contextual schema therapy workshop for social anxiety symptoms – A randomized controlled trial. JCBS 2023; 29(3): 67-75.
- Zainal N H, Newman M G. Inflammation mediates depression and generalized anxiety symptoms predicting executive function impairment after 18 years. JAD 2022; 296(13): 465-475.
- Porcel J, Montalban X. Anticholinesterasics in the treatment of cognitive impairment in Multiple Sclerosis. J Neurol Sci 2006; 245(1-2): 177-81.
- Arnett PA, Higginson CI, Randolph JJ. Depression in Multiple Sclerosis: relationship to planning ability. J Int Neuropsychol Soc 2001; 7(6): 665-74.
- Moscati A, Flint J, Kendler K S. Classification of anxiety disorders comorbid with major depression: common or distinct influences on risk?. JDA 2016; 33(6): 120-127.
- Cantón-Cortés D, Cortés M R, Cantón J. Child Sexual Abuse, Attachment Style, and Depression The Role of the Characteristics of Abuse. JIV 2015; 30(11): 420-436.
- Linares L, Jauregui P, Herrero-Fernández D, Estévez A. Mediationg Role of Mindfulness as a Trait Between Attachment Styles and Depressive Symptoms. JP 2016; 7(4): 1-16.
15. Uchenna E, Scott B, Jane N, Terri D, Evan J, Alexandra M, Shauna F, Florin O. The potential of repetitive transcranial magnetic stimulation for addressing sleep difficulties in children with autism – A brief communication. JSM 2024; 118(4):78-80
16.Yuichiro S, Yoshikazu U. Transcranial magnetic stimulation. COBS 2024; 58, (2): 101-396.
17.Chun-Hung C, Shaw-Ji C. Home-based therapy with continuous cranial electrotherapy stimulation after repetitive transcranial magnetic stimulation in a patient with severe depression and anxiety during COVID-19 pandemic: case report and meta-analysis of randomized controlled trials. PRCR 2024; 3(1): 100-220.
18.Renato MendesS, Monara N, Leonardo PeresdeS, Sabrina N, Álison S, AnaV, etal. Hypothesis on the potential of repetitive transcranial magnetic stimulation to modulate neurochemical pathways and circadian rhythm in ADHD. JMH 2024. 189(11): 111-411.
19.Jiajing W, Sheng Z, Xiaoying Z, Lanxiang W, Xinmiao M, Hong J, Chengjie M, Jing C, Chun-feng L. Objective sleep enhancement in Parkinson's disease: A sham-controlled trial of low-frequency repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex. PRD 2024; 126 (8): 107050.
20.Wassermann EM, Lisanby SH. Therapeutic application of repetitive transcranial magnetic stimulation: A review. JCN 2011;112(8):1367-1377.
21.Fitzgerald P B, Hoy K E, Herring S E, McQueen S, Peachey A V, Segrave R A, Daskalakis Z J. A double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depression. JAD 2012; 139(2): 193-198.
22.Baron RA, Mueller BA, Wolfe MT. Self-efficacy and entrepreneurs adoption of unattainable goals: The restraining effects of self-control. JBV 2016;31(1):55-71.
23.Kedzior KK, Rajput V, Price G, Lee J, Martin-Iverson M. Cognitive correlates of repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant depression-a pilot study. BMC Psychiatry 2012;12(1):163-171.
24.Concerto C, Lanza G, Cantone M, Ferri R, Pennisi G, Bella R, et al. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study. IJPCP 2015;19(4):252-258.
25.Victor Rossetto B, Gabriel T K, Valquíria Aparecida da S, Luciana MB, at al . Posterior insula repetitive transcranial magnetic stimulation for chronic pain in patients with Parkinson disease – pain type matters: A double-blinded randomized sham-controlled trial. NCCN 2024; 54(5): 102994.
- Beck At, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuringdepression. JAMA 1961; 4 (1): 561-571.